ID   B16F10/mGM
AC   CVCL_L292
SY   B16-GMCSF; B16GMCSF; B16-GM; B16GM
DR   CLO; CLO_0050762
DR   RCB; RCB1158
DR   TOKU-E; 4042
DR   Wikidata; Q54752525
RX   PubMed=9886252;
RX   PubMed=23890195;
CC   Doubling time: 17.9 hours (PubMed=23890195).
CC   Transfected with: MGI; MGI:1339752; Csf2.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
RX   PubMed=9886252; DOI=10.1002/jlb.65.1.102;
RA   Kumar R., Yoneda J., Fidler I.J., Dong Z.-Y.;
RT   "GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis
RT   by normal murine macrophages and poorly tumorigenic in
RT   immune-compromised mice.";
RL   J. Leukoc. Biol. 65:102-108(1999).
//
RX   PubMed=23890195; DOI=10.1186/1475-2867-13-75;
RA   Danciu C., Falamas A., Dehelean C., Soica C., Radeke H.,
RA   Barbu-Tudoran L., Bojin F., Cinta Pinzaru S., Munteanu M.F.;
RT   "A characterization of four B16 murine melanoma cell sublines
RT   molecular fingerprint and proliferation behavior.";
RL   Cancer Cell Int. 13:75.1-75.12(2013).
//